BioCentury
ARTICLE | Clinical News

Bind Therapeutics, AstraZeneca preclinical data

July 13, 2015 7:00 AM UTC

In mouse xenograft models of small cell lung cancer (SCLC) and diffuse large B cell lymphoma (DLBCL), AZD2811 inhibited tumor growth and led to tumor regression. Data were presented at the American A...